| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 78, 107-113, Copyright © 1994 by Endocrine Society
ARTICLES |
K Furui, N Suganuma, S Tsukahara, Y Asada, F Kikkawa, M Tanaka, T Ozawa and Y Tomoda
Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Japan.
To analyze the structure of LH in three patients with immunologically anomalous LH, the whole coding region of the LH beta-subunit gene was examined. These patients were infertile, and their serum LH levels could not be measured with an immunoassay kit. Immunoblotting of the LH beta-subunit showed no marked changes in the molecular size of LH beta. Genomic DNA was extracted from peripheral lymphocytes of the patients and normal controls, and LH beta genes were amplified by the polymerase chain reaction technique, using primer pairs that are capable of specifically amplifying only the LH beta gene without interference by the CG beta genes. No deletions were observed in the coding regions of the LH beta gene of the patients. Nucleotide sequencing revealed two nucleotide substitutions in the LH beta gene of the patients, which cause amino acid replacements from Trp8 (TGG) to Arg8 (CGG) and Ile15 (ATC) to Thr15 (ACC). Restriction fragment length polymorphism analysis in three families indicated that the affected probands were homozygous, and their family members were heterozygous, except for their husbands. The heterozygotes showed reduced detectability with the LH immunoassay kit. These results suggest that these amino acid replacements are responsible for this immunologically anomalous variant.
This article has been cited by other articles:
![]() |
A. P N Themmen An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms Reproduction, September 1, 2005; 130(3): 263 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome Endocr. Rev., April 1, 2005; 26(2): 251 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Powell, D. Piersma, M. E. Kevenaar, I. L. van Staveren, A. P. N. Themmen, B. J. Iacopetta, and E. M. J. J. Berns Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1653 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lamminen, M. Jiang, P. R. Manna, P. Pakarinen, H. Simonsen, R. J. Herrera, and I. Huhtaniemi Functional study of a recombinant form of human LH{beta}-subunit variant carrying the Gly102Ser mutation found in Asian populations Mol. Hum. Reprod., October 1, 2002; 8(10): 887 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jiang, T. Lamminen, P. Pakarinen, J. Hellman, P. Manna, R. J. Herrera, and I. Huhtaniemi A novel Ala-3Thr mutation in the signal peptide of human luteinizing hormone {beta}-subunit: potentiation of the inositol phosphate signalling pathway and attenuation of the adenylate cyclase pathway by recombinant variant hormone Mol. Hum. Reprod., March 1, 2002; 8(3): 201 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Manna, L. Joshi, V. N. Reinhold, M. L. Aubert, N. Suganuma, K. Pettersson, and I. T. Huhtaniemi Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone Hum. Mol. Genet., February 1, 2002; 11(3): 301 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akhmedkhanov, P. Toniolo, A. Zeleniuch-Jacquotte, K. S. Pettersson, and I. T. Huhtaniemi Luteinizing Hormone, Its {beta}-Subunit Variant, and Epithelial Ovarian Cancer: The Gonadotropin Hypothesis Revisited Am. J. Epidemiol., July 1, 2001; 154(1): 43 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bergendah and J. D. Veldhuis Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: III. Luteinizing hormone heterogeneity: a medical physiologist's perspective Hum. Reprod., June 1, 2001; 16(6): 1058 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.H. Nilsson, M. Kaleva, H. Virtanen, A.M. Haavisto, K. Pettersson, and I.T. Huhtaniemi Disparate response of wild-type and variant forms of LH to GnRH stimulation in individuals heterozygous for the LH{beta} variant allele Hum. Reprod., February 1, 2001; 16(2): 230 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text] |
||||
![]() |
D.W. Cramer, K.S.I. Petterson, R.L. Barbieri, and I.T. Huhtaniemi Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone Hum. Reprod., October 1, 2000; 15(10): 2103 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akhmedkhanov, P. Toniolo, A. Zeleniuch-Jacquotte, K. Pettersson, and I. Huhtaniemi Genetic Variant of Luteinizing Hormone and Risk of Breast Cancer in Older Women Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 839 - 842. [Abstract] [Full Text] |
||||
![]() |
L.N. Ramanujam, W.-X. Liao, A.C. Roy, and S.C. Ng Association of molecular variants of luteinizing hormone with male infertility Hum. Reprod., April 1, 2000; 15(4): 925 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shuto, T. Nakano, N. Sanno, H. Domoto, H. Sugihara, and I. Wakabayashi Reduced Growth Hormone Receptor Messenger Ribonucleic Acid in an Aged Man with Chronic Malnutrition and Growth Hormone Resistance J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2320 - 2323. [Abstract] [Full Text] |
||||
![]() |
J. S. Tapanainen, R. Koivunen, B. C. J. M. Fauser, A. E. Taylor, R. N. Clayton, M. Rajkowa, D. White, S. Franks, L. Anttila, K. S. I. Pettersson, et al. A New Contributing Factor to Polycystic Ovary Syndrome: The Genetic Variant of Luteinizing Hormone J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1711 - 1715. [Abstract] [Full Text] |
||||
![]() |
A. W. van den Beld, I. T. Huhtaniemi, K. S. L. Pettersson, H. A. P. Pols, D. E. Grobbee, F. H. de Jong, and S. W. J. Lamberts Luteinizing Hormone and Different Genetic Variants, as Indicators of Frailty in Healthy Elderly Men J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1334 - 1339. [Abstract] [Full Text] |
||||
![]() |
I. Galeraud-Denis, P. Bouchard, M. Herlicoviez, E. Marie, and S. Carreau Inhibitory effect of plasma obtained from hypophysectomized and control women on the assay of bioactive luteinizing hormone Hum. Reprod., February 1, 1999; 14(2): 312 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eskola-Williams and G. J. Fagan Misleading Results with Opus® Magnum hLH Assay • A spokesman from Behring replies: Clin. Chem., October 1, 1997; 43(10): 2008 - 2010. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |